PRECIPIO, INC. Increase (Decrease) in Derivative Liabilities
PRECIPIO, INC. (PRPO) reported Increase (Decrease) in Derivative Liabilities of $100.00 thousand for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-05-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDerivativeLiabilities · last filed 2020-11-13
- PRECIPIO, INC. increase (decrease) in derivative liabilities for the quarter ending 2020-03-31 was $100.00K.
- PRECIPIO, INC. increase (decrease) in derivative liabilities for the quarter ending 2019-09-30 was $0.00.
- PRECIPIO, INC. increase (decrease) in derivative liabilities for the quarter ending 2019-06-30 was $0.00.
- PRECIPIO, INC. increase (decrease) in derivative liabilities for the quarter ending 2018-12-31 was $400.00K.
| Period end | Increase (Decrease) in Derivative Liabilities 3 month | Increase (Decrease) in Derivative Liabilities 6 month | Increase (Decrease) in Derivative Liabilities 9 month |
|---|---|---|---|
| 2020-03-31 | $100.00K 10-Q · filed 2020-05-14 | ||
| 2019-09-30 | $0.00 10-Q · filed 2020-11-13 | $0.00 derived: sum of 2 quarters · filed 2020-11-13 | $100.00K 10-Q · filed 2020-11-13 |
| 2019-06-30 | $0.00 10-Q · filed 2020-08-13 | $100.00K 10-Q · filed 2020-08-13 | |
| 2018-12-31 | $400.00K 10-Q · filed 2019-08-09 | $400.00K derived: sum of 2 quarters · filed 2019-11-13 | |
| 2018-09-30 | $0.00 10-Q · filed 2019-11-13 | $0.00 10-Q · filed 2019-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |